Borrelia is a genus of spiral, motile bacteria known as spirochaetes. Members of this genus are notable for causing human illness, most famously Lyme disease but also several forms of relapsing fever. These organisms are gram-negative and have a characteristic helical shape with periplasmic flagella that allow them to move through viscous environments such as connective tissue.
Biology and distinguishing features
At the microscopic level Borrelia species are long, thin and flexible. Their anatomy differs from many other bacteria because their flagella lie between the inner membrane and outer membrane (in the periplasm), producing corkscrew motility. Borrelia are difficult to culture in standard laboratory media, and molecular methods such as PCR are often used for detection and species identification.
Transmission, reservoirs and disease forms
These bacteria are zoonotic and vector-borne. Transmission pathways depend on the species: Lyme borreliae (for example Borrelia burgdorferi and Borrelia afzelii) are transmitted primarily by hard-bodied Ixodes ticks and maintained in nature by small mammals and birds, while several relapsing fever borreliae are associated with soft ticks of the genus Ornithodoros or, in the case of epidemic relapsing fever, with human lice (lice).
- Common reservoirs include small mammals such as mice and voles; rodents are important amplifying hosts for many species (rodents).
- Typical human illnesses: Lyme disease (Lyme disease) and various forms of relapsing fever (relapsing fever).
Clinical presentation and public health importance
Lyme disease often begins with a localized skin rash (erythema migrans), fever, fatigue and muscle aches; if untreated it can progress to joint, heart and nervous system involvement. Relapsing fever is characterized by repeated episodes of high fever separated by afebrile intervals. Both conditions are significant public health concerns in parts of Europe, North America and Africa, depending on the local Borrelia species and vectors.
Diagnosis, treatment and prevention
Diagnosis combines clinical assessment with laboratory testing: serology (antibody tests), PCR, and, in specialized settings, culture. Treatment typically involves antibiotics—doxycycline, amoxicillin or ceftriaxone are commonly used depending on disease stage and severity. Prevention focuses on reducing vector exposure (tick checks, protective clothing, tick control), reservoir management, and public education in endemic regions.
Species diversity and historical notes
There are roughly three dozen described Borrelia species, with about a dozen regularly implicated in human disease. The genus includes distinct groups associated with Lyme borreliosis and with relapsing fever. Important historical milestones include the clinical recognition of Lyme disease in the 1970s and the identification of Borrelia burgdorferi as its causative agent. For further introduction and scientific details see specialized resources linked above.